PDE5 Inhibitors: Mechanism, Clinical Uses & Safety Overview
PDE5 inhibitors (Phosphodiesterase Type 5 inhibitors) are a class of medications primarily used to treat erectile dysfunction (ED) and certain cardiovascular conditions such as pulmonary arterial hypertension (PAH). These agents enhance vasodilation by inhibiting the PDE5 enzyme, which regulates cyclic guanosine monophosphate (cGMP) levels in smooth muscle cells.
Mechanism of Action
By blocking PDE5, these drugs increase cGMP concentrations, promoting smooth muscle relaxation and improved blood flow—particularly in the corpus cavernosum during sexual stimulation.
Common PDE5 Inhibitors
Viagra (sildenafil)
Cialis (tadalafil)
Levitra (vardenafil)
Clinical Applications
Erectile dysfunction
Pulmonary arterial hypertension (specific formulations)
Safety Considerations
Common side effects include headache, flushing, nasal congestion, and dyspepsia. PDE5 inhibitors must not be combined with nitrate medications due to the risk of severe hypotension. Medical evaluation is essential to ensure safe and appropriate use.